(Q22242284)

7 January 2021

Conversion of MHPG to vanillylmandelic acid. Implications for the importance of urinary MHPG

1 reference

7 January 2021

Biochemical diagnosis of pheochromocytoma: which test is best?

1 reference

7 January 2021

Neurotransmitter alterations in a model of perinatal hypoxic-ischemic brain injury

1 reference

7 January 2021

Effects of hypoxia-ischemia on monoamine metabolism in the immature brain

1 reference

7 January 2021

Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture.

1 reference

7 January 2021

Dopamine induces apoptosis in cultured rat striatal neurons; possible mechanism of D2-dopamine receptor neuron loss during aging.

1 reference

7 January 2021

Cytotoxic and genotoxic potential of dopamine

1 reference

7 January 2021

Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde

1 reference

7 January 2021

Reduced MPTP neurotoxicity in striatum of the mutant mouse tottering.

1 reference

7 January 2021

Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection.

1 reference

7 January 2021

Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease.

1 reference

7 January 2021

The neuronal norepinephrine transporter in experimental heart failure: evidence for a posttranscriptional downregulation

1 reference

7 January 2021

Evidence for formation of hydroxyl radicals during reperfusion after global cerebral ischaemia in rats using salicylate trapping and microdialysis

1 reference

7 January 2021

Dopaminergic neurotoxicity of cyanide: neurochemical, histological, and behavioral characterization.

1 reference

7 January 2021

Reactive dopamine metabolites and neurotoxicity: implications for Parkinson's disease

1 reference

7 January 2021

Urinary MHPG sulfate as a marker of central norepinephrine metabolism: a commentary

1 reference

7 January 2021

Inhibition of gastrointestinal motility by MPTP via adrenergic and dopaminergic mechanisms

1 reference

7 January 2021

Role of dopamine and other stimuli of mucosal bicarbonate secretion in duodenal protection

1 reference

7 January 2021

Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp

1 reference

7 January 2021

Urinary excretion of catecholamines and their metabolites in pheochromocytoma

1 reference

7 January 2021

Heterogeneous myocardial catecholamine concentrations in patients with congestive heart failure

1 reference

7 January 2021

Value of the plasma norepinephrine/3,4-dihydroxyphenylglycol ratio for the diagnosis of pheochromocytoma

1 reference

7 January 2021

Studies on the metabolism of norepinephrine, epinephrine and their o-methyl analogs by partially purified enzyme preparations

1 reference

7 January 2021

A radioenzymatic microassay for simultaneous measurement of catecholamines and their deaminated metabolites

1 reference

7 January 2021

3-methoxy-4-hydroxyphenylglycol sulfate in brain and cerebrospinal fluid.

1 reference

7 January 2021

Metabolism in the human of 3, 4-dihydroxymandelic acid, one of the metabolites of noradrenaline and adrenaline

1 reference

7 January 2021

Reduction of biogenic aldehydes by aldehyde reductase and alcohol dehydrogenase from human liver

1 reference

7 January 2021

Origin and distribution of 3-methoxy-4-hydroxyphenylglycol in body fluids

1 reference

7 January 2021

Enzymology and subcellular localization of aldehyde oxidation in rat liver. Oxidation of 3,4-dihydroxyphenylacetaldehyde derived from dopamine to 3,4-dihydroxyphenylacetic acid

1 reference

7 January 2021

3-Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine

1 reference

7 January 2021

3-Methoxy-4-hydroxyphenylglycol sulfate, a new metabolite of epinephrine and norepinephrine

1 reference

7 January 2021

Presence of free, sulfate and glucuronide conjugated 3-methoxy-4-hydroxyphenylglycol (MHPG) in human brain, cerebrospinal fluid and plasma

1 reference

7 January 2021

Plasma and cerebrospinal fluid 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) as indices of brain norepinephrine metabolism in primates.

1 reference

7 January 2021

Norepinephrine transmitter metabolite is a selective cell death messenger in differentiated rat pheochromocytoma cells

1 reference

7 January 2021

Endogenous dopamine modulates jejunal sodium absorption during high-salt diet in young but not in adult rats

1 reference

7 January 2021

The evaluation of 4-hydroxy-3-methoxyphenylglycol sulfate as a possible marker of central norepinephrine turnover. Studies in healthy volunteers and depressed patients

1 reference

7 January 2021

Presence of N-methyl-norsalsolinol in the CSF: correlations with dopamine metabolites of patients with Parkinson's disease

1 reference

7 January 2021

Determination of homovanillic acid turnover in man

1 reference

7 January 2021

Effect of eating bananas on plasma free and sulfate-conjugated catecholamines

1 reference

7 January 2021

Direct determination of homovanillic acid release from the human brain, and indicator of central dopaminergic activity

1 reference

7 January 2021

Regional homovanillic acid production in humans

1 reference

7 January 2021

Cereal ingestion and catecholamine excretion

1 reference

7 January 2021

A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter

1 reference

7 January 2021

Source and physiological significance of plasma 3,4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycol

1 reference

7 January 2021

Noradrenaline reuptake and plasma dihydroxyphenylglycol during sustained changes in sympathetic activity in rabbits.

1 reference

7 January 2021

The neuronal and extraneuronal origins of plasma 3-methoxy-4-hydroxyphenylglycol in rats

1 reference

7 January 2021

Regional origins of 3-methoxy-4-hydroxyphenylglycol in plasma: effects of chronic sympathetic nervous activation and denervation, and acute reflex sympathetic stimulation

1 reference

7 January 2021

The molecular cloning and expression of a human synaptic vesicle amine transporter that suppresses MPP+ toxicity

1 reference

7 January 2021

Increased cardiac production of dihydroxyphenylalanine (DOPA) during sympathetic stimulation in anaesthetized dogs

1 reference

7 January 2021

An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.

1 reference

7 January 2021

Monoamine oxidase inhibitors prevent striatal neuronal necrosis induced by transient forebrain ischemia.

1 reference

7 January 2021

Neuronal and extraneuronal uptake and metabolism of catecholamines

1 reference

7 January 2021

Central and peripheral dopamine D1/DA1 receptor modulation of gastric secretion and experimental gastric mucosal injury

1 reference

7 January 2021

Neonatal hypoxic-ischemic or excitotoxic striatal injury results in a decreased adult number of substantia nigra neurons

1 reference

7 January 2021

Apoptosis in substantia nigra following developmental hypoxic-ischemic injury.

1 reference

7 January 2021

Evidence for reduction of norepinephrine uptake sites in the failing human heart

1 reference

7 January 2021

Transmural heterogeneity of norepinephrine uptake in failing human hearts

1 reference

7 January 2021

Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause

1 reference

7 January 2021

1 reference

7 January 2021

Is the autoxidation of catecholamines involved in ischemia-reperfusion injury?

1 reference

7 January 2021

An endogenous dopaminergic neurotoxin: implication for Parkinson's disease

1 reference

7 January 2021

Aldose reductase, a key enzyme in the oxidative deamination of norepinephrine in rats

1 reference

7 January 2021

3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells.

1 reference

7 January 2021

Increased striatal dopamine turnover following acute administration of rotenone to mice

1 reference

7 January 2021

Catecholamine monoamine oxidase a metabolite in adrenergic neurons is cytotoxic in vivo.

1 reference

7 January 2021

Myocardial interstitial norepinephrine and dihydroxyphenylglycol levels during ischemia and reperfusion

1 reference

7 January 2021

Hydrogen peroxide production by monoamine oxidase during ischemia/reperfusion

1 reference

7 January 2021

Liquid chromatographic method for the determination of 3,4-dihydroxyphenylethylene glycol and 3,4-dihydroxymandelic acid in plasma

1 reference

7 January 2021

Neurobiology of retinal dopamine in relation to degenerative states of the tissue

1 reference

7 January 2021

Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation

1 reference

7 January 2021

The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines

1 reference

7 January 2021

Effects of aldehyde/aldose reductase inhibition on neuronal metabolism of norepinephrine.

1 reference

7 January 2021

Dopamine transporters and neuronal injury

1 reference

7 January 2021

Isoquinoline neurotoxins in the brain and Parkinson's disease

1 reference

7 January 2021

3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis

1 reference

7 January 2021

The vesicular monoamine transporter: from chromaffin granule to brain

1 reference

7 January 2021

Determination of differential activities of soluble and membrane-bound catechol-O-methyltransferase in tissues and erythrocytes

1 reference

7 January 2021

Aldose reductase: an aldehyde scavenging enzyme in the intraneuronal metabolism of norepinephrine in human sympathetic ganglia

1 reference

7 January 2021

Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism.

1 reference

7 January 2021

Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma

1 reference

7 January 2021

Mice lacking the norepinephrine transporter are supersensitive to psychostimulants

1 reference

7 January 2021

Hydrogen peroxide production by monoamine oxidase during ischemia-reperfusion in the rat brain.

1 reference

7 January 2021

Adrenaline and amine oxidase

1 reference

7 January 2021

Urinary conjugates of 4-hydroxy-3-methoxyphenylethylene glycol do not provide an index of brain amine turnover in man

1 reference

7 January 2021

Central and regional normetadrenaline in evaluation of neurogenic aspects of hypertension: aid to diagnosis of phaeochromocytoma

1 reference

7 January 2021

Changes in plasma free 3,4-dihydroxyphenylethylene glycol and noradrenaline levels after acute alcohol administration

1 reference

7 January 2021

Dihydroxyphenylglycol and dihydroxymandelic acid during intravenous infusions of noradrenaline

1 reference

7 January 2021

Neuronal Re-Uptake of Noradrenaline by Sympathetic Nerves in Humans

1 reference

7 January 2021

Dopamine and the kidney: ten years on

1 reference

7 January 2021

Derivation of urinary dopamine from plasma dihydroxyphenylalanine in humans

1 reference

7 January 2021

Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism?

1 reference

7 January 2021

Effects of ordinary meals on plasma concentrations of 3,4-dihydroxyphenylalanine, dopamine sulphate and 3,4-dihydroxyphenylacetic acid.

1 reference

7 January 2021

Specific skin lesions occurring in a patient with Hodgkin's lymphoma

1 reference

7 January 2021

Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter.

1 reference

7 January 2021

Disposition and Metabolism of MHPG in Humans: Application to Studies in Depression

1 reference

7 January 2021

Measurement of norepinephrine and 3,4-dihydroxyphenylglycol in urine and plasma for the diagnosis of pheochromocytoma

1 reference

7 January 2021

Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2

1 reference

7 January 2021

Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency

1 reference

7 January 2021

Human class I alcohol dehydrogenases catalyze the oxidation of glycols in the metabolism of norepinephrine

1 reference

7 January 2021

A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine

1 reference

7 January 2021

Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections

1 reference

7 January 2021

Profound neuronal plasticity in response to inactivation of the dopamine transporter

1 reference

7 January 2021

X-ray crystal structure of human dopamine sulfotransferase, SULT1A3. Molecular modeling and quantitative structure-activity relationship analysis demonstrate a molecular basis for sulfotransferase substrate specificity

1 reference

7 January 2021

Determinants of cardiac noradrenaline depletion in human congestive failure

1 reference

7 January 2021

Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease

1 reference

7 January 2021

Catecholamine Metabolism in Neuroblastoma 1 2

1 reference

7 January 2021

Activation of pro-apoptotic cascade by dopamine in renal epithelial cells is fully dependent on hydrogen peroxide generation by monoamine oxidases

1 reference

7 January 2021

Simultaneous assay of noradrenaline and its deaminated metabolite, dihydroxyphenylglycol, in plasma: a simplified approach to the exclusion of phaeochromocytoma in patients with borderline elevation of plasma noradrenaline concentration

1 reference

7 January 2021

Some enzymic aspects of the production of oxidized or reduced metabolites of catecholamines and 5-hydroxytryptamine by brain tissues.

1 reference

7 January 2021

Kinetics of homovanillic acid and determination of its production rate in humans

1 reference

7 January 2021

Norepinephrine metabolism in humans studied by deuterium labelling: turnover of 4-hydroxy-3-methoxyphenylglycol

1 reference

7 January 2021

Norepinephrine metabolism in man using deuterium labelling: origin of 4-hydroxy-3-methoxymandelic acid

1 reference

7 January 2021

Transient hypoxia alters striatal catecholamine metabolism in immature brain: an in vivo microdialysis study.

1 reference

7 January 2021

Effects of transient forebrain ischemia and pargyline on extracellular concentrations of dopamine, serotonin, and their metabolites in the rat striatum as determined by in vivo microdialysis.

1 reference

7 January 2021

Physiological roles of dopamine and neuropeptides in the retina

1 reference

7 January 2021

Noradrenaline release and uptake in isolated small dense cored vesicles from rat seminal ducts

1 reference

7 January 2021

The inactivation of adrenaline in vivo in man

1 reference

7 January 2021

A single amino acid, glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3

1 reference

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

7 January 2021

3-Methoxy-4-Hydroxyphenethyleneglycol Production by Human Brain in Vivo

1 reference

7 January 2021

Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol

1 reference

7 January 2021

Biochemical detection of phaeochromocytoma: should we still be measuring urinary HMMA?

1 reference

7 January 2021

Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects

1 reference

7 January 2021

Reduction of tissue noradrenaline content in the isolated perfused rat heart during ischemia: importance of monoamine oxidation

1 reference

7 January 2021

Norepinephrine and dihydroxyphenylglycol effluxes from sympathetic nerve endings during hypoxia and reoxygenation in the isolated rat heart

1 reference

7 January 2021

Vesicular neurotransmitter transporters: from bacteria to humans

1 reference

7 January 2021

Dopamine produced by the stomach may act as a paracrine/autocrine hormone in the rat.

1 reference

7 January 2021

MAO inhibitors, clorgyline and lazabemide, prevent hydroxyl radical generation caused by brain ischemia/reperfusion in mice

1 reference

7 January 2021

Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.

1 reference

7 January 2021

Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart

1 reference

7 January 2021

Neuronal reuptake of norepinephrine and production of dihydroxyphenylglycol by cardiac sympathetic nerves in the anesthetized dog

1 reference

7 January 2021

Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine

1 reference

7 January 2021

Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure

1 reference

7 January 2021

Cardiac sympathetic nerve function in congestive heart failure

1 reference

7 January 2021

Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure

1 reference

7 January 2021

Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension

1 reference

7 January 2021

Reduction of cardiac tyrosine hydroxylase activity in experimental congestive heart failure. Its role in the depletion of cardiac norepinephrine stores

1 reference

7 January 2021

Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanism and metabolic requirements

1 reference

7 January 2021

Nerve terminal damage in cerebral ischemia: greater susceptibility of catecholamine nerve terminals relative to serotonin nerve terminals.

1 reference

7 January 2021

TURNOVER AND METABOLISM OF CATECHOLAMINES IN PATIENTS WITH PHEOCHROMOCYTOMA

1 reference

7 January 2021

Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans

1 reference

7 January 2021

Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamber-specific contributor to beta-adrenoceptor downregulation.

1 reference

7 January 2021

Sympathetic discharge to mesenteric organs and the liver. Evidence for substantial mesenteric organ norepinephrine spillover

1 reference

7 January 2021

A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines

1 reference

7 January 2021

Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results

1 reference

7 January 2021

Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors

1 reference

7 January 2021

Sources and physiological significance of plasma dopamine sulfate.

1 reference

7 January 2021

Catecholamine Metabolism in Neuroblastoma: Kinetics of Conversion of3H-3-methoxy-4-hydroxyphenylglycol to3H-3-methoxy-4-hydroxymandelic Acid

1 reference

7 January 2021

Neurotransmitter specificity of sympathetic denervation in Parkinson's disease

1 reference

7 January 2021

Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology

1 reference

7 January 2021

Abnormalities in color vision and contrast sensitivity in Parkinson's disease

1 reference

7 January 2021

Orthostatic hypotension from sympathetic denervation in Parkinson's disease

1 reference

7 January 2021

Participation of type A monoamine oxidase in the activated deamination of brain monoamines shortly after reperfusion in rats.

1 reference

7 January 2021

Is there a third peripheral catecholaminergic system? Endogenous dopamine as an autocrine/paracrine substance derived from plasma DOPA and inactivated by conjugation

1 reference

7 January 2021

Catecholamine toxicity in cerebral cortex in dissociated cell culture

1 reference

7 January 2021

Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice.

1 reference

7 January 2021

Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein

1 reference

7 January 2021

Pheochromocytoma in Italy: a multicentric retrospective study

1 reference

7 January 2021

Design, production and characterization of antibodies discriminating between the phenol- and monoamine-sulphating forms of human phenol sulphotransferase

1 reference

7 January 2021

Plasma metanephrines in the diagnosis of pheochromocytoma

1 reference

7 January 2021

Cardiac sympathetic denervation in Parkinson disease

1 reference

7 January 2021

Sympathetic neurocirculatory failure in Parkinson disease: Evidence for an etiologic role of alpha-synuclein

1 reference

7 January 2021